Emerald Development Managers — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Torigen Pharmaceuticalstorigen.com inSeries A · May 2022 · $13M

BiotechFarmington, US

Ashley Kalinauskas(Executive Officer)inMark Suckow(Executive Officer, Director)Brad Poff(Executive Officer)Terry Dew(Executive Officer)

Co-investorsChloe Capital Connecticut Innovations Launchpad Venture Group Gaingels SoGal Ventures The Fund

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.